| 1 | ANIFROLUMAB | 1件:  Anifrolumab Anifrolumab | 1件:  D11082 
                
                    D11082
                
             (Name: Anifrolumab) | 2件:  IFNAR1 IFNAR1, IFNAR2 💬 | 18件:  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件:  46 46, 49 | 
| 2 | Anifrolumab (MEDI-546) | 1件:  Anifrolumab Anifrolumab | 1件:  D11082 
                
                    D11082
                
             (Name: Anifrolumab) | 2件:  IFNAR1 IFNAR1, IFNAR2 💬 | 18件:  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件:  46 46 | 
| 3 | Anifrolumab 1000 mg | 1件:  Anifrolumab Anifrolumab | 1件:  D11082 
                
                    D11082
                
             (Name: Anifrolumab) | 2件:  IFNAR1 IFNAR1, IFNAR2 💬 | 18件:  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件:  49 49 | 
| 4 | Anifrolumab 300 mg | 1件:  Anifrolumab Anifrolumab | 1件:  D11082 
                
                    D11082
                
             (Name: Anifrolumab) | 2件:  IFNAR1 IFNAR1, IFNAR2 💬 | 18件:  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件:  49 49 |